TANG CAPITAL MANAGEMENT LLC Q2 2017 Filing

Filed August 14, 2017

Portfolio Value

$281.7B

Holdings

5

Report Date

Q2 2017

Filing Type

13F-HR

All Holdings (5 positions)

#StockSharesValue% PortfolioType
1
HRTXHERON THERAPEUTICS INC
8,643,739$119.7B42.49%
2
—LA JOLLA PHARMACEUTICAL CO
3,440,419$102.4B36.35%
3
—IGNYTA INC
4,763,602$49.3B17.50%
4
BMRNBIOMARIN PHARMACEUTICAL INC
90,215$8.2B2.91%
5
—CYCLACEL PHARMACEUTICALS INC
559,900$2.1B0.75%